HIGHLIGHTS
SUMMARY
COVID-19 Patients Non-COVID-19 Patients (N=21) (N=66) Mean age (years) 70 ± 12.2 68.9 ± 12.5 Male gender 6 (28.5%) 37 (56%) Urinary catheterization 17 (80.9%) 34 (51.5%) When analyzing the antibiotic resistance profiles before and after the onset of the COVID-19 pandemic, the authors found similar resistance rates, the only significant differences being in the case of gentamicin, with a decreased resistance, from 82.6% to 52.5% (p=0.001), and in the case of ceftazidime + avibactam (CAZ-AVI), which presented a higher . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.